New developments in hepatitis B, C and G virus

Authors	R.E.J.H. Sentjens
Supervisors	G.N.J. Tytgat
Co-supervisors	H.W. Reesink M.G.H.M. Beld
Award date	7 February 2003
Number of pages	189
Organisations	Faculty of Medicine (AMC-UvA)
Document type	PhD thesis
Note	Research conducted at: CLDO
Downloads	Thesis Cover Titlepage CONTENTS Chapter 1 Outline of the thesis CHAPTER 2 INTRODUCTION Chapter 3 Performance of the new Bayer VERSANTTM HCV 3.0 RNA assay (bDNA) for quantitation of HCV RNA in plasma and serum: Conversion to International Units and comparison with the Roche Cobas Amplicor HCV Monitor 2.0 assay Chapter 4 Comparison of a new diagnostic HCV antigen assay with the VERSANTTM HCV3.0 bDNA assay to monitor viral decline in chronic hepatitis C patients treated with high dose Interferon. Chapter 5 Detection and quantitation of hepatitis C virus RNA in feces of chronically infected individuals Chapter 6 VIRAL KINETICS OF HCV RNA IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH 18 MU INTERFERON ALPHA DAILY Chapter 7 Induction treatment with high dose Interferon alpha combined with Ribavirin and Amantadine for interferon naïve patients with chronic hepatitis C, A 2 arm randomised pilot study Chapter 8 FAMCICLOVIR AND ALPHA-INTERFERON COMBINATION THERAPY FOR HBeAg NEGATIVE CHRONIC HEPATITIS B PATIENTS, A 2 arm randomised pilot study Chapter 9 HGV/GBV-C transmission by blood components in patients undergoing open-heart surgery Chapter 10 Summary/Samenvatting Dankwoord Stellingen Cover
Permalink to this page

Back

UvA-DARE